Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism
Phase: PHASE1 | Sponsor: Centre for Addiction and Mental Health | Compound: Psilocybin
- Status
- recruiting
- Institution
- Centre for Addiction and Mental Health
- Start date
- 2024-11-01
- End date
- 2027-08-01
- Registry ID
- NCT06731621
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.